Case Study: Treatment of Ulcerative Colitis with coMra Therapy

Patient Information

• Gender: Male
• Age: 47 years old
• Diagnosis: Ulcerative Colitis (1990)
• Initially proctosigmoiditis
• Progressed to pancolitis (2014)

Initial Symptoms

1. Severe abdominal pain and cramps during relapses (8-10/10 pain scale)
2. 12-14 diarrhea stools per day during relapses
3. 3-4 relapses per year
4. Blood and mucus in stool (during relapses and when >8 stools/day)
5. Fatigue and weight loss during relapses

Treatment Protocol

• Device: coMra Delta 980 (home user version)
• Initial treatment: Twice daily for 20 days
• Subsequent treatments: Reduced and modified in cooperation with therapists

Additional Therapies

• Pharmacotherapy: Anti-inflammatories (oral and rectal)
• Before coMra: 5-6 pills daily + suppositories
• After coMra: 2 pills daily, no suppositories

Results

Fecal Calprotectin Test

• Sept 2013: 312 (positive for UC)
• Sept 2015: Borderline
• Feb 2016 to present: Negative for UC

Symptom Improvements

1. Bowel movements:

• Before: 5 per day (usually diarrhea)
• After: 1 per day (well-formed stool)

2. No relapses since start of care
3. No pain or cramps since start of care
4. Significant reduction in medication
5. No dietary restrictions (except milk)

Patient Feedback

• Improved comfort and quality of life
• No limitations on diet (except milk)
• Reduced frequency of gastrointestinal issues
• Highly recommends coMra therapy

Conclusion

This case study demonstrates significant improvement in ulcerative colitis symptoms and overall quality of life using coMra therapy. The patient experienced a reduction in pain, normalized bowel movements, elimination of relapses, and decreased medication use. The fecal calprotectin test results support the clinical improvements observed.